Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0751068B2 - Method for producing mevalonic acid - Google Patents
[go: Go Back, main page]

JPH0751068B2 - Method for producing mevalonic acid - Google Patents

Method for producing mevalonic acid

Info

Publication number
JPH0751068B2
JPH0751068B2 JP4962387A JP4962387A JPH0751068B2 JP H0751068 B2 JPH0751068 B2 JP H0751068B2 JP 4962387 A JP4962387 A JP 4962387A JP 4962387 A JP4962387 A JP 4962387A JP H0751068 B2 JPH0751068 B2 JP H0751068B2
Authority
JP
Japan
Prior art keywords
ifo
mevalonic acid
atcc
culture
nrrl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4962387A
Other languages
Japanese (ja)
Other versions
JPS63216487A (en
Inventor
章 遠藤
誠治 小池
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adeka Corp
Original Assignee
Asahi Denka Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Denka Kogyo KK filed Critical Asahi Denka Kogyo KK
Priority to JP4962387A priority Critical patent/JPH0751068B2/en
Priority to AT88103319T priority patent/ATE86664T1/en
Priority to EP88103319A priority patent/EP0281143B1/en
Priority to DE8888103319T priority patent/DE3878946T2/en
Priority to ES88103319T priority patent/ES2053596T3/en
Publication of JPS63216487A publication Critical patent/JPS63216487A/en
Priority to US07/629,184 priority patent/US5149641A/en
Priority to GR930400328T priority patent/GR3007316T3/el
Publication of JPH0751068B2 publication Critical patent/JPH0751068B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明はメバロン酸の製造方法、特に、メバロン酸を高
収率で得る方法に関するものである。
TECHNICAL FIELD The present invention relates to a method for producing mevalonic acid, and more particularly to a method for obtaining mevalonic acid in high yield.

尚、メバロン酸は酸型とラクトン型の2通りの構造を示
すが、相互に変換することが公知であり、以下本明細書
では特に断らない限り、両型を総称してメバロン酸とい
う。
Mevalonic acid has two types of structures, an acid type and a lactone type, but it is known that they are mutually converted, and hereinafter, unless otherwise specified, both types are generically referred to as mevalonic acid.

〔従来の技術及び発明が解決しようとする問題点 メバロン酸は、ライト等によって始めて単離された物質
であり(ジャーナル・オブ・ジ・アメリカン・ケミカル
・ソサイエティ(Journal of the American Chemical S
ociety)78巻、5273〜5275頁、1956年)コレステロール
を始めとする各種イソプレノイド化合物の重要な中間体
として知られている。
[Problems to be Solved by Prior Art and Invention Mevalonic acid is a substance first isolated by Wright et al. (Journal of the American Chemical Society).
78), 5273-5275, 1956) Known as an important intermediate of various isoprenoid compounds such as cholesterol.

又、メバロン酸は、種々の微生物及び植物に対して成育
促進作用を有する等、生物の代謝に重要な役割を果たし
ているため、微生物、植物等の成長促進剤として用いら
れ、また、ピレスロイド系農薬、ユビキノン(呼吸系補
酵素)、ドリコール(多糖類の生合成必須因子)、及び
脂溶性ビタミン等の前駆体等に用いられる。
Further, mevalonic acid is used as a growth promoter for microorganisms, plants, etc. because it has an important role in the metabolism of organisms, such as having a growth promoting action on various microorganisms and plants, and it is also a pyrethroid pesticide. , Ubiquinone (respiratory coenzyme), dolichol (polysaccharide biosynthesis essential factor), and precursors of fat-soluble vitamins and the like.

従来これらの研究には化学合成されたラセミ体が使用さ
れており、天然型のメバロン酸は入手し難いものであっ
た。
Conventionally, chemically synthesized racemates have been used in these studies, and natural mevalonic acid was difficult to obtain.

天然型のメバロン酸の醗酵法による製造は、アプライド
・マイクロバイオロジー(Applied Microbiology)16
965(1968)や米国特許第3,617,447号明細書にサッカロ
マイコプシス・フィブリゲラ NRRL Y−9069を用いた
例が記載されているが、その収量は低く、700〜1000μg
/mlにとどまり、工業的な生産には到っていないのが現
状である。
Fermentation of natural mevalonic acid is carried out by Applied Microbiology 16 ,
965 (1968) and U.S. Pat. No. 3,617,447 describe examples using Saccharomycopsis fibriguera NRRL Y-9069, but the yield is low, 700-1000 μg.
The current situation is that the production is still limited to / ml and has not reached industrial production.

従って、本発明の目的は、工業的に実施可能な程度に収
量の良いメバロン酸の製造方法を提供することにある。
Therefore, an object of the present invention is to provide a method for producing mevalonic acid which is industrially practicable and has a good yield.

〔問題点を解決するための手段〕[Means for solving problems]

本発明のメバロン酸の製造方法の必須の構成要件はサッ
カロマイコプシス・フィブリゲラ(Saccharomycopsis f
ibuligera)IFO 0107、IFO 0103、IFO 0104、IFO 0
105、IFO 0106、IFO 0109、IFO 0111、IFO 1665、I
FO 1711、IFO 1745、AHU 4113、IAM 4247、OUT 60
71、HUT 7234、ATCC 2080、ATCC 2082、ATCC 208
8、ATCC 20145、ATCC 24945、ATCC 44872、ATCC 46
252、ATCC 46253、ATCC 46949、ATCC 52921、NRRL
Y−1060、NRRL Y−1064、NRRL Y−2385、NRRL Y
−7061、NRRL Y−7221、NRRL Y−7324、NRRL Y−
7464、DSM 70554及びこれらの変異株からなる群から選
択した1種以上の微生物を培養し、好ましくはIFO 010
7を培養し、次いでその培養物からメバロン酸を得るこ
とである。
The essential component of the method for producing mevalonic acid of the present invention is Saccharomycopsis f.
ibuligera) IFO 0107, IFO 0103, IFO 0104, IFO 0
105, IFO 0106, IFO 0109, IFO 0111, IFO 1665, I
FO 1711, IFO 1745, AHU 4113, IAM 4247, OUT 60
71, HUT 7234, ATCC 2080, ATCC 2082, ATCC 208
8, ATCC 20145, ATCC 24945, ATCC 44872, ATCC 46
252, ATCC 46253, ATCC 46949, ATCC 52921, NRRL
Y-1060, NRRL Y-1064, NRRL Y-2385, NRRL Y
-7061, NRRL Y-7221, NRRL Y-7324, NRRL Y-
7464, DSM 70554 and one or more microorganisms selected from the group consisting of these mutants are cultivated, preferably IFO 010
Culturing 7 and then obtaining mevalonic acid from that culture.

尚、IFO、ATCC、NRRL、DSM、AHU、IAM、OUT、HUTはそれ
ぞれ財団法人醗酵研究所保存菌株、アメリカン・タイプ
カルチャー・コレクション保存菌株、ARSノーザンレジ
ョナル・リサーチセンター保存菌株、ドイチェ・ザンム
ルング・フォン・ミクロオルガニズメン保存菌株、北海
道大学農学部保存菌株、東京大学応用微生物研究所保存
菌株、大阪大学工業部醗酵工学科保存菌株、広島大学工
学部醗酵工学科保存菌株を示す。
In addition, IFO, ATCC, NRRL, DSM, AHU, IAM, OUT, and HUT are the fermentation strains preserved by the Fermentation Institute, the American Type Culture Collection preserved strains, the ARS Northern Regional Research Center preserved strains, and Deutsche Zamrumung von, respectively. -Preserved strains of microorganismen, preserved strains of Hokkaido University Faculty of Agriculture, preserved strains of Institute of Applied Microbiology, University of Tokyo, preserved strains of fermentation engineering department of Osaka University, and preserved strains of fermentation engineering department of Hiroshima University.

本発明により、即ち上記微生物を用いてメバロン酸を製
造するには、例えば、米国特許第3,617,447号明細書に
示される如く、公知の方法を用いることができるが、好
ましくは以下の方法によるのが良い。
According to the present invention, that is, in order to produce mevalonic acid using the above-mentioned microorganism, for example, as shown in U.S. Pat.No. 3,617,447, a known method can be used, but preferably the following method is used. good.

即ち、炭素源、有機態窒素源、細胞膜の可溶化作用を持
つ非イオン界面活性剤及び無機塩類を所定量含有する培
地に微生物を接種し、20〜40℃、好ましくは25〜35℃で
震盪培養するか、100〜500rpm、好ましくは200〜400rp
m、0.2〜1.5VVM、好ましくは0.5〜1.0VVMで通気撹拌培
養し、所定時間培養した後、培養物における培養液(培
養物の培養濾液)中の炭素源濃度の測定、培養物のpHの
測定又は溶存酸素量の測定により、前記基質を培養物に
流加(添加)する。このような基質の流加を必要回数行
い、それ以上メバロン酸の生産量が向上しないと判断し
た時点で培養を終了する。培養終了後、培養物を遠心分
離、濾過等公知の方法で菌体を除き、逆浸透法、減圧蒸
留等により濃縮するか、ブタノールや酢酸エチルを用い
た向流分配法或いはシリカゲル、ポーラスポリマー樹
脂、イオン交換樹脂等を使用したカラムクロマトグラフ
ィ法、分子蒸留法、結晶化法等の公知の精製技術の組合
せにより処理してメバロン酸を得ることができる。
That is, a medium containing a predetermined amount of a carbon source, an organic nitrogen source, a nonionic surfactant having a cell membrane solubilizing action and inorganic salts is inoculated with a microorganism, and shaken at 20 to 40 ° C, preferably 25 to 35 ° C. Culture or 100-500 rpm, preferably 200-400rp
m, 0.2 to 1.5 VVM, preferably 0.5 to 1.0 VVM, aeration and agitation culture, and after culturing for a predetermined time, measurement of carbon source concentration in the culture solution (culture filtrate of the culture), pH of the culture The substrate is fed (added) to the culture by measurement or measurement of the amount of dissolved oxygen. Such feeding of the substrate is performed a required number of times, and the culture is terminated when it is determined that the mevalonic acid production amount is not further improved. After completion of the culture, the culture is centrifuged or filtered to remove the cells by a known method, and then concentrated by a reverse osmosis method, vacuum distillation or the like, or a countercurrent distribution method using butanol or ethyl acetate, silica gel, or a porous polymer resin. , Mevalonic acid can be obtained by treatment with a combination of known purification techniques such as column chromatography using an ion exchange resin, molecular distillation, crystallization and the like.

尚、本発明の方法における培地には、本発明の目的の範
囲内で、所望により消泡剤等を添加することができる。
また培養液中の炭素源濃度の測定は、グルコースオキシ
ダーゼを用いる酵素法等により行い、上記の「培養液」
は、培養物を遠心分離、濾過等により菌体等を除いた溶
液部である。
If desired, an antifoaming agent or the like can be added to the medium in the method of the present invention within the scope of the object of the present invention.
In addition, the measurement of the carbon source concentration in the culture solution is performed by an enzyme method using glucose oxidase, and the above-mentioned "culture solution"
Is a solution part in which the bacterial cells and the like have been removed from the culture by centrifugation, filtration and the like.

〔実施例〕〔Example〕

以下に本発明の実施例を示すが、本発明はこれらに限定
されるものではない。
Examples of the present invention will be shown below, but the present invention is not limited thereto.

尚、実施例、比較例におけるメバロン酸の定量は以下の
ようにして行った。
In addition, the quantitative determination of mevalonic acid in Examples and Comparative Examples was performed as follows.

〔メバロン酸の定量方法〕[Method of quantifying mevalonic acid]

試料溶液0.8mlをスピッチ管に取り、1N−HCl溶液を用い
てpHを2に調整する。これにNa2SO41gを加え、更に酢酸
エチル2.0mlを加えて撹拌後、上層を取る。下層に更に
酢酸エチル2.0mlを加えて撹拌後、上層を取り前回の上
層と合わせる。再度この操作を行い、酢酸エチル層計6.
0mlを得、これを蒸発乾固する。この乾固物を3,4−ジメ
トキシベンズアルデヒドを内部標準としてガスクロマト
グラフィにより定量した。尚、ガスクロマトグラフィの
条件は以下の通り。カラムサイズ:直径3mm長さ1000mm
(ステンカラム液相:10%Thermon−3000カラムサポー
ト:chromosorb W AW−DMCS 80〜100メッシュ カラム温度:180℃ インジェクション温度:230℃ キャリアーガス:N2(40ml/分) 〔実施例1〕 グルコース10重量%、マルトエキストラクト1重量%、
ペプトン0.5重量%、イーストエキストラクト0.1重量
%、KH2PO40.3重量%、MgSO4・7H2O0.05重量%、CaCO31
重量%、トライトン X−100(膜の可溶化作用を持つ
非イオン界面活性剤)0.05重量%、残部水からなる培地
20と200mlを用意し、該200mlの培地にサッカロマイコ
プシス・フィブリゲラIFO 0107を1白金耳接種し28℃
で3日間震盪培養しておいたものを、上記20の培地に
接種し、28℃、回転数300rpm、通気量20/分でグルコ
ース濃度、pH、溶存酸素量を測定しつつ通気撹拌培養し
た。
0.8 ml of the sample solution is put into a pitch tube, and the pH is adjusted to 2 with 1N-HCl solution. To this, 1 g of Na 2 SO 4 was added, 2.0 ml of ethyl acetate was further added, and after stirring, the upper layer was taken. 2.0 ml of ethyl acetate was added to the lower layer, and after stirring, the upper layer was taken and combined with the previous upper layer. Repeat this operation again, total 6.
0 ml is obtained, which is evaporated to dryness. The dried solid was quantified by gas chromatography using 3,4-dimethoxybenzaldehyde as an internal standard. The conditions for gas chromatography are as follows. Column size: Diameter 3mm Length 1000mm
(Stain column liquid phase: 10% Thermon-3000 column support: chromosorb W AW-DMCS 80-100 mesh Column temperature: 180 ° C Injection temperature: 230 ° C Carrier gas: N 2 (40 ml / min) [Example 1] Glucose 10 % By weight, malt extract 1% by weight,
Peptone 0.5%, yeast extract 0.1 wt%, KH 2 PO 4 0.3 wt%, MgSO 4 · 7H 2 O0.05 wt%, CaCO 3 1
A medium consisting of wt%, Triton X-100 (nonionic surfactant having a solubilizing effect on the membrane) 0.05 wt%, and the balance water.
Prepare 20 and 200 ml, and inoculate 1 200 ml of Saccharomycopsis fibrillella IFO 0107 into the medium and incubate at 28 ° C.
The medium which had been shake-cultured for 3 days was inoculated into the above-mentioned 20 medium, and the culture was carried out with aeration and stirring while measuring the glucose concentration, pH and dissolved oxygen content at 28 ° C., a rotation speed of 300 rpm, and an aeration rate of 20 / min.

培養3日目に培養液中のグルコース濃度が5%以下とな
り、その直後にpHが7を越え、溶存酸素量が極小値を通
過したことを確認し、この時点でグルコースの50重量%
水溶液を2.0kg流加し、培養を継続した。更に、培養6
日目及び培養9日目にそれぞれグルコースの50重量%水
溶液を2.0kgを流加し、計12日間培養を継続し培養を終
了した。培養終了後、培養物から得たメバロン酸を、前
記定量法により測定したところ、メバロン酸の量は1210
0μg/mlであった。
It was confirmed that the glucose concentration in the culture solution became 5% or less on the third day of the culture, and immediately after that, the pH exceeded 7, and the dissolved oxygen amount passed the minimum value.
2.0 kg of the aqueous solution was fed and the culture was continued. Furthermore, culture 6
On the day and the 9th day of the culture, 2.0 kg of a 50% by weight aqueous solution of glucose was fed, respectively, and the culture was continued for a total of 12 days to complete the culture. After completion of the culture, mevalonic acid obtained from the culture was measured by the above-mentioned quantitative method, and the amount of mevalonic acid was 1210.
It was 0 μg / ml.

〔実施例2、比較例1〕 グルコース10重量%、マルトエキストラクト1重量%、
ペプトン0.5重量%、イーストエキストラクト0.1重量
%、KH2PO40.3重量%、MgSO4・7H2O0.05重量%、CaCO31
重量%、塩化アンモニウム0.3重量%、残部水からなる
培地20と200mlを用意し、該200mlの培地にサッカロマ
イコプシス・フィブリゲラIFO 0107を1白金耳接種し2
8℃で3日間震盪培養しておいたものを、上記20の培
地に接種し、28℃、回転数300rpm、通気量20/分で通
気撹拌培養した。
Example 2 and Comparative Example 1 Glucose 10% by weight, Malto Extract 1% by weight,
Peptone 0.5%, yeast extract 0.1 wt%, KH 2 PO 4 0.3 wt%, MgSO 4 · 7H 2 O0.05 wt%, CaCO 3 1
Prepare 20 and 200 ml of a medium consisting of 20% by weight, 0.3% by weight of ammonium chloride, and the balance of water, and inoculate 1 ml of Saccharomycopsis fibrigella IFO 0107 into the 200 ml of the medium.
The medium which had been shake-cultured at 8 ° C. for 3 days was inoculated into the above-mentioned 20 medium, and culture was carried out with aeration and stirring at 28 ° C., a rotation number of 300 rpm, and an aeration rate of 20 / min.

6日間培養を継続して得られたメバロン酸の量は3010μ
g/mlであった。
The amount of mevalonic acid obtained by continuing the culture for 6 days was 3010μ.
It was g / ml.

また、サッカロマイコプシス・フィブリゲラのIFO 010
7をNRRL Y−9069に替えたほかは同様にして培養した
場合(比較例1)には、6日間培養を継続して得られた
メバロン酸の量は780μg/mlであった。
In addition, Saccharomycopsis fibriguera IFO 010
When 7 was replaced with NRRL Y-9069 and cultured in the same manner (Comparative Example 1), the amount of mevalonic acid obtained by continuing the culture for 6 days was 780 μg / ml.

〔実施例3〕 実施例1の培地の10mlを試験管に入れ、121℃15分で殺
菌しサッカロマイコプシス・フィブリゲラの、表−1に
示した通りの菌株をそれぞれ1白金耳接種し28℃、回転
数250rpmで震盪培養した。4日目、8日目に50重量%グ
ルコース水溶液を1.0gづつ流加して12日間培養後、2500
rpm10分間遠心分離し、濾過液中のメバロン酸を定量し
た。このようにして得られたメバロン酸の量を表−1に
示す。
[Example 3] 10 ml of the medium of Example 1 was placed in a test tube, sterilized at 121 ° C for 15 minutes, and 1 platinum loop of each strain of Saccharomycopsis fibrigella shown in Table 1 was inoculated. Culturing was carried out by shaking at 250C and 250 rpm. On the 4th and 8th days, 1.0 g of 50 wt% glucose aqueous solution was fed to each well and cultured for 12 days.
After centrifugation at rpm for 10 minutes, mevalonic acid in the filtrate was quantified. The amount of mevalonic acid thus obtained is shown in Table 1.

〔実施例4〕 実施例1で得た培養物22を回転数5000rpmで遠心分離
し濾液15を得た。これを逆浸透膜を用いて5に濃縮
後50重量%リン酸水を用いてpH2とし、5の酢酸エチ
ルで3回抽出し、酢酸エチル層15を得た。これを0.02
N水酸化ナトリウム水5に転溶し、50重量%リン酸水
にてpH2とした後、ダイヤイオンHP−20(登録商標)カ
ラム(1)を通した。この流出液を、5の酢酸エチ
ルで3回抽出し、酢酸エチル層15を得た。これを無水
硫酸ナトリウムにて脱水後蒸発乾固させた。この乾固物
を少量のアセトン/ベンゼン(1/7)に溶解させ、シリ
カゲルカラムクロマトグラフィー(ワユーゲル(−200
(登録商標)、1500g)により分離した。その後メバロ
ン酸を含む画分を乾固し、無色の油状物質91.4gを得
た。
Example 4 The culture 22 obtained in Example 1 was centrifuged at a rotation speed of 5000 rpm to obtain a filtrate 15. This was concentrated to 5 using a reverse osmosis membrane, adjusted to pH 2 with 50% by weight aqueous phosphoric acid, and extracted 3 times with ethyl acetate of 5 to obtain an ethyl acetate layer 15. 0.02 for this
The solution was dissolved in N-sodium hydroxide water 5 and adjusted to pH 2 with 50% by weight phosphoric acid water, and then passed through Diaion HP-20 (registered trademark) column (1). The effluent was extracted 3 times with ethyl acetate of 5 to obtain an ethyl acetate layer 15. This was dried over anhydrous sodium sulfate and evaporated to dryness. This dried solid was dissolved in a small amount of acetone / benzene (1/7) and subjected to silica gel column chromatography (Wagel (-200
(Registered trademark), 1500 g). Then, the fraction containing mevalonic acid was dried to obtain 91.4 g of a colorless oily substance.

比旋光度〔α▲〕25 D▼=−22.0゜ (C=3.20、エタノール)であった。The specific optical rotation [α ▲] 25 D ▼ = -22.0 ° (C = 3.20, ethanol).

〔発明の効果〕〔The invention's effect〕

本発明のメバロン酸の製造方法によれば、工業的に実施
可能な程度に高収量でメバロン酸を得ることができる。
According to the method for producing mevalonic acid of the present invention, mevalonic acid can be obtained in a high yield as industrially feasible.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】サッカロマイコプシス・フィブリゲラ(Sa
ccharomycopsis fibuligera)IFO 0107、IFO 0103、I
FO 0104、IFO 0105、IFO 0106、IFO 0109、IFO 01
11、IFO 1665、IFO 1711、IFO 1745、AHU 4113、IA
M 4247、OUT 6071、HUT 7234、ATCC 2080、ATCC 2
082、ATCC 2088、ATCC 20145、ATCC 24945、ATCC 4
4872、ATCC 46252、ATCC 46253、ATCC 46949、ATCC
52921、NRRL Y−1060、NRRL Y−1064、NRRL Y
−2385、NRRL Y−7061、NRRL Y−7221、NRRL Y−
7324、NRRL Y−7464、DSM 70554及びこれらの変異株
からなる群から選択した1種以上の微生物を培養し、次
いでその培養物からメバロン酸を得ることを特徴とする
メバロン酸の製造方法。
1. Saccharomycopsis fibrigella (Sa
ccharomycopsis fibuligera) IFO 0107, IFO 0103, I
FO 0104, IFO 0105, IFO 0106, IFO 0109, IFO 01
11, IFO 1665, IFO 1711, IFO 1745, AHU 4113, IA
M 4247, OUT 6071, HUT 7234, ATCC 2080, ATCC 2
082, ATCC 2088, ATCC 20145, ATCC 24945, ATCC 4
4872, ATCC 46252, ATCC 46253, ATCC 46949, ATCC
52921, NRRL Y-1060, NRRL Y-1064, NRRL Y
-2385, NRRL Y-7061, NRRL Y-7221, NRRL Y-
A method for producing mevalonic acid, which comprises culturing at least one microorganism selected from the group consisting of 7324, NRRL Y-7464, DSM 70554 and mutants thereof, and then obtaining mevalonic acid from the culture.
JP4962387A 1987-03-04 1987-03-04 Method for producing mevalonic acid Expired - Lifetime JPH0751068B2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP4962387A JPH0751068B2 (en) 1987-03-04 1987-03-04 Method for producing mevalonic acid
AT88103319T ATE86664T1 (en) 1987-03-04 1988-03-03 PROCESS FOR THE PRODUCTION OF MEVALONIC ACID.
EP88103319A EP0281143B1 (en) 1987-03-04 1988-03-03 Process for producing mevalonic acid
DE8888103319T DE3878946T2 (en) 1987-03-04 1988-03-03 METHOD FOR PRODUCING MEVALONIC ACID.
ES88103319T ES2053596T3 (en) 1987-03-04 1988-03-03 A PROCESS FOR THE PRODUCTION OF MEVALONIC ACID.
US07/629,184 US5149641A (en) 1987-03-04 1990-12-17 Process for producing mevalonic acid
GR930400328T GR3007316T3 (en) 1987-03-04 1993-03-11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4962387A JPH0751068B2 (en) 1987-03-04 1987-03-04 Method for producing mevalonic acid

Publications (2)

Publication Number Publication Date
JPS63216487A JPS63216487A (en) 1988-09-08
JPH0751068B2 true JPH0751068B2 (en) 1995-06-05

Family

ID=12836356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4962387A Expired - Lifetime JPH0751068B2 (en) 1987-03-04 1987-03-04 Method for producing mevalonic acid

Country Status (1)

Country Link
JP (1) JPH0751068B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220052965A (en) * 2019-08-28 2022-04-28 다니스코 유에스 인크. Skin care composition comprising mevalonolactone

Also Published As

Publication number Publication date
JPS63216487A (en) 1988-09-08

Similar Documents

Publication Publication Date Title
US5036011A (en) Novel Aureobasidium sp. microorganisms and method for obtaining the same, and method for preparing erythritol with the same
EP0158194B1 (en) Process for the production of l-carnitine in a microbiological way
JP2792600B2 (en) Mevalonic acid producing bacteria
EP0152949A2 (en) Process for the preparation of 6-hydroxynicotinic acid
EP0410430B1 (en) Process for the microbiological discontinual preparation of L-carnitine
JPH0751068B2 (en) Method for producing mevalonic acid
EP0248401B1 (en) Enzyme and process for its preparation
JPH0789938B2 (en) Method for producing mevalonic acid
DE3041224C2 (en)
US5149641A (en) Process for producing mevalonic acid
JPH0789940B2 (en) Manufacturing method of mevalonic acid
JPH0789939B2 (en) Method for producing mevalonic acid
EP0383248B1 (en) Process for the production of mevalonic acid
JP2964163B2 (en) Method for producing R (-)-1,3-butanediol
DE69801789T2 (en) Process for the preparation of optically active 1,2,4-butanetriols
NO802863L (en) PROCEDURE FOR THE PREPARATION OF 2,5-DICETOGLUCONIC ACID
JPH0569512B2 (en)
JPS5953838B2 (en) Method for producing β-hydroxyvaleric acid
JPS6250473B2 (en)
JPH0521557B2 (en)
JPS6257312B2 (en)
JPS5953839B2 (en) Method for producing (−)-α-hydroxymethylbutyric acid
JPS5921600B2 (en) Method for producing D(-)-β-hydroxyisobutyric acid
JPS6244915B2 (en)
JPS62158494A (en) Production of (r)-3-halogeno-1,2-propanediol

Legal Events

Date Code Title Description
S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term